Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04046731 · ClinicalTrials.gov registry record · NA
Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation
A NA study of Allergy, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 187
- Enrollment target
- 1
- Study location
NCT04046731 is a NA study of Allergy that has completed, run by Mayo Clinic. The registered enrollment target is 187 participants, below the 320-participant average among 15 other Allergy trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04046731, a NA study of Allergy, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 187 participants
- Enrollment target
- 1
- Study location
Study Summary
The researchers are trying to develop an allergy skin test to help predict allergic responses to medications commonly given to patients during surgery.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Skin Testing
Study Locations (1)
Florida
- Mayo Clinic - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2019-09-20 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04046731
The ClinicalTrials.gov registry entry for NCT04046731 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 187 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 320-participant average among 15 other Allergy trials with a reported enrollment target (42% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Allergy appearing as the primary indexed condition, and to 1 intervention - of which Skin Testing is the first listed.
NCT04046731 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04046731 about?
NCT04046731 is a clinical study titled "Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation". The researchers are trying to develop an allergy skin test to help predict allergic responses to medications commonly given to patients during surgery.
What is the current status of trial NCT04046731?
This trial is currently completed. It is a NA study. The enrollment target is 187 participants. The study started on 2019-09-20. Estimated completion is 2021-12-31.
What conditions does trial NCT04046731 study?
This clinical trial studies the following conditions: Allergy.
What interventions are being tested in trial NCT04046731?
The interventions under investigation include: Skin Testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04046731?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04046731 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Allergy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Understanding Allergies and Sensitizations in Healthy and Allergic Individuals
RECRUITING
-
The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron
RECRUITING · Phase 4
-
Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
RECRUITING · Phase 3
-
Childhood Allergy and the Neonatal Environment
ACTIVE NOT RECRUITING
-
Urban Environmental Factors and Childhood Asthma
COMPLETED
-
Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.